These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 32071304)

  • 1. Pyridoxine induces glutathione synthesis via PKM2-mediated Nrf2 transactivation and confers neuroprotection.
    Wei Y; Lu M; Mei M; Wang H; Han Z; Chen M; Yao H; Song N; Ding X; Ding J; Xiao M; Hu G
    Nat Commun; 2020 Feb; 11(1):941. PubMed ID: 32071304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress on EAAC1 is involved in MPTP-induced glutathione depletion and motor dysfunction.
    Aoyama K; Matsumura N; Watabe M; Nakaki T
    Eur J Neurosci; 2008 Jan; 27(1):20-30. PubMed ID: 18093171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte.
    Chen PC; Vargas MR; Pani AK; Smeyne RJ; Johnson DA; Kan YW; Johnson JA
    Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2933-8. PubMed ID: 19196989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin.
    Shao W; Zhang SZ; Tang M; Zhang XH; Zhou Z; Yin YQ; Zhou QB; Huang YY; Liu YJ; Wawrousek E; Chen T; Li SB; Xu M; Zhou JN; Hu G; Zhou JW
    Nature; 2013 Feb; 494(7435):90-4. PubMed ID: 23242137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
    Ahuja M; Ammal Kaidery N; Yang L; Calingasan N; Smirnova N; Gaisin A; Gaisina IN; Gazaryan I; Hushpulian DM; Kaddour-Djebbar I; Bollag WB; Morgan JC; Ratan RR; Starkov AA; Beal MF; Thomas B
    J Neurosci; 2016 Jun; 36(23):6332-51. PubMed ID: 27277809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of NQO1 and Neuroprotection by a Novel Compound KMS04014 in Parkinson's Disease Models.
    Son HJ; Choi JH; Lee JA; Kim DJ; Shin KJ; Hwang O
    J Mol Neurosci; 2015 Jun; 56(2):263-72. PubMed ID: 25702135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo.
    Guo B; Xu D; Duan H; Du J; Zhang Z; Lee SM; Wang Y
    Biol Pharm Bull; 2014; 37(2):274-85. PubMed ID: 24305623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astrocytic JWA expression is essential to dopaminergic neuron survival in the pathogenesis of Parkinson's disease.
    Miao SH; Sun HB; Ye Y; Yang JJ; Shi YW; Lu M; Hu G; Zhou JW
    CNS Neurosci Ther; 2014 Aug; 20(8):754-62. PubMed ID: 24628733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S-allyl cysteine protects against MPTP-induced striatal and nigral oxidative neurotoxicity in mice: participation of Nrf2.
    García E; Santana-Martínez R; Silva-Islas CA; Colín-González AL; Galván-Arzate S; Heras Y; Maldonado PD; Sotelo J; Santamaría A
    Free Radic Res; 2014 Feb; 48(2):159-67. PubMed ID: 24147739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress.
    Zhu YL; Sun MF; Jia XB; Cheng K; Xu YD; Zhou ZL; Zhang PH; Qiao CM; Cui C; Chen X; Yang XS; Shen YQ
    Int Immunopharmacol; 2019 Jan; 66():19-27. PubMed ID: 30419450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uric acid demonstrates neuroprotective effect on Parkinson's disease mice through Nrf2-ARE signaling pathway.
    Huang TT; Hao DL; Wu BN; Mao LL; Zhang J
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1443-1449. PubMed ID: 28986252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the Nrf2 signaling pathway and neuroprotection of nigral dopaminergic neurons by a novel synthetic compound KMS99220.
    Lee JA; Son HJ; Choi JW; Kim J; Han SH; Shin N; Kim JH; Kim SJ; Heo JY; Kim DJ; Park KD; Hwang O
    Neurochem Int; 2018 Jan; 112():96-107. PubMed ID: 29158022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pinostrobin Exerts Neuroprotective Actions in Neurotoxin-Induced Parkinson's Disease Models through Nrf2 Induction.
    Li C; Tang B; Feng Y; Tang F; Pui-Man Hoi M; Su Z; Ming-Yuen Lee S
    J Agric Food Chem; 2018 Aug; 66(31):8307-8318. PubMed ID: 29961319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress.
    Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM
    Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease.
    Katila N; Bhurtel S; Shadfar S; Srivastav S; Neupane S; Ojha U; Jeong GS; Choi DY
    Neuropharmacology; 2017 Oct; 125():396-407. PubMed ID: 28807678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Nrf2-mediated gene transcription by extremely potent synthetic triterpenoids attenuate dopaminergic neurotoxicity in the MPTP mouse model of Parkinson's disease.
    Kaidery NA; Banerjee R; Yang L; Smirnova NA; Hushpulian DM; Liby KT; Williams CR; Yamamoto M; Kensler TW; Ratan RR; Sporn MB; Beal MF; Gazaryan IG; Thomas B
    Antioxid Redox Signal; 2013 Jan; 18(2):139-57. PubMed ID: 22746536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of madecassoside in early stage of Parkinson's disease induced by MPTP in rats.
    Xu CL; Qu R; Zhang J; Li LF; Ma SP
    Fitoterapia; 2013 Oct; 90():112-8. PubMed ID: 23876367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection by Paeoniflorin in the MPTP mouse model of Parkinson's disease.
    Zheng M; Liu C; Fan Y; Yan P; Shi D; Zhang Y
    Neuropharmacology; 2017 Apr; 116():412-420. PubMed ID: 28093210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice.
    Patil SP; Jain PD; Ghumatkar PJ; Tambe R; Sathaye S
    Neuroscience; 2014 Sep; 277():747-54. PubMed ID: 25108167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.